Application Nr Approved Date Route Status External Links
NDA212194 None Subcutaneous None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Givlaari Is Indicated For The Treatment Of Adults With Acute Hepatic Porphyria (ahp). Givlaari Is An Aminolevulinate Synthase 1-Directed Small Interfering Rna Indicated For The Treatment Of Adults With Acute Hepatic Porphyria (ahp). ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Givosiran Sodium

Comments